Neuronetics Inc
Research Neuronetics Inc (STIM) on Bullrun: market cap USD 227.06M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerSTIM
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryMedical Devices
- CurrencyUSD
- Market capUSD 227.06M
- Financial periodQ1 2026
- RevenueUSD 34.45M
- Net income-USD 10.79M
- Free cash flow-USD 9.62M
- Gross margin46.9%
Valuation Snapshot
latest market cap is USD 227.06M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 149.16M | -USD 39.00M | -USD 21.20M | 48.5% | -0.59 | USD 28.13M | USD 65.81M | USD 22.38M |
| FY2024 | USD 74.89M | -USD 43.71M | -USD 32.46M | 72.3% | -1.38 | USD 18.46M | USD 55.15M | USD 27.71M |
| FY2023 | USD 71.35M | -USD 30.19M | -USD 34.41M | 72.5% | -1.05 | USD 59.68M | USD 59.28M | USD 34.19M |
| FY2022 | USD 65.21M | -USD 37.16M | -USD 34.01M | 76.3% | -1.38 | USD 70.34M | USD 35.95M | USD 57.06M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-25 | USD 227.06M | n/a | n/a | n/a |
| 2025 | 2025-12-31 | USD 95.21M | n/a | n/a | n/a |
| 2024 | 2024-12-31 | USD 89.64M | n/a | n/a | n/a |
| 2023 | 2023-12-29 | USD 83.91M | n/a | n/a | n/a |
| 2022 | 2022-12-30 | USD 187.01M | n/a | n/a | n/a |
| 2021 | 2021-12-31 | USD 117.72M | n/a | n/a | n/a |
About Neuronetics Inc
Neuronetics, Inc. engages in providing in office treatments for patients with neurohealth disorders in the United States and internationally. The company provides NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive disorder.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Neuronetics Inc's market cap?
Neuronetics Inc's market capitalization is USD 227.06M.
What does Neuronetics Inc do?
Neuronetics, Inc. engages in providing in office treatments for patients with neurohealth disorders in the United States and internationally. The company provides NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive disorder. Its NeuroStar Advanced Therapy System uses transcranial magnetic stimulation to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood.